Inventor
KLUENDER HAROLD C E
US12 patents
⚠️ This page may combine multiple inventors who share the name “KLUENDER HAROLD C E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
4 patentsUS6960601B2Nov 1, 2005
Preparation and use of imidazole derivatives for treatment of obesity
BAYER PHARMACEUTICALS CORP26 citations91
US7563791B2Jul 21, 2009
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
BAYER PHARMACEUTICALS CORP14 citations82
US6689883B1Feb 10, 2004
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
BAYER PHARMACEUTICALS CORP20 citations82
US6903101B1Jun 7, 2005
Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
BAYER PHARMACEUTICALS CORP21 citations81
DIXON JULIE A
4 patentsUS8143393B2Mar 27, 2012
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A5 citations59
US8129379B2Mar 6, 2012
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A4 citations59
US8829185B2Sep 9, 2014
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A2 citations58
US8338595B2Dec 25, 2012
Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A0 citations48
BAYER AG
3 patentsUS6353006B1Mar 5, 2002
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
BAYER AG33 citations88
US5863915AJan 26, 1999
Substituted 4-arylbutyric acid derivatives as matrix metalloprotease
BAYER AG16 citations73
US5939583AAug 17, 1999
Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
BAYER AG9 citations64